Requirements for procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells (Sixth Edition 2021)

This document was published by the National Pathology Accreditation Advisory Council (NPAAC) whilst under the governance of the Department of Health and Aged Care. From 1 July 2021, the Australian Commission on Safety and Quality in Health Care (the Commission) assumed responsibility for coordinating the National Pathology Accreditation (NPA) Scheme and supporting the development of the pathology accreditation standards.

Requirements for procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells (Sixth Edition 2021) is currently in use.

The Commission is undergoing a review process for each of the pathology standards. To remain up to date on upcoming consultations and to provide input, please visit the pathology accreditation standards and sign up now for ongoing updates.

For enquiries about the NPA Scheme or the resources, email pathology@safetyandquality.gov.au.

The Requirements for Procedures Related to the Collection, Processing, Storage and Issue of Human Haemopoietic Progenitor Cells (Sixth Edition 2021) is a revision of the 2015 edition and sets out the minimum standards for facilities involved in donor selection, collection, processing, storage or disposal of directed minimally manipulated:

• haemopoietic progenitor cells (HPC)
• cord blood; and
• donor lymphocytes which are used for haemopoietic reconstitution; and
• donor lymphocytes which are issued for subsequent manufacture of a TGA approved product or under an approved clinical trial.

The scope of the Requirements to include donor lymphocytes used for haemopoietic reconstitution and donor lymphocytes which are issued for manufacture of a TGA approved product or under an approved clinical trial.